These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31209059)

  • 1. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
    Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
    Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP7 Signaling in
    Eikesdal HP; Becker LM; Teng Y; Kizu A; Carstens JL; Kanasaki K; Sugimoto H; LeBleu VS; Kalluri R
    Mol Cancer Res; 2018 Oct; 16(10):1568-1578. PubMed ID: 29934328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
    Mukhopadhyay A; Berrett KC; Kc U; Clair PM; Pop SM; Carr SR; Witt BL; Oliver TG
    Cell Rep; 2014 Jul; 8(1):40-9. PubMed ID: 24953650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
    Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
    DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
    Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
    Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
    Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma.
    Yang J; Lewis JS; Zi J; Andl T; Lee E; Andl CD; Liu Q; Beauchamp RD; Means AL
    J Pathol; 2024 Sep; 264(1):4-16. PubMed ID: 38922866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
    Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
    Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation.
    Tan X; Tong L; Li L; Xu J; Xie S; Ji L; Fu J; Liu Q; Shen S; Liu Y; Xiao Y; Gao F; Moses RE; Bardeesy N; Wang Y; Zhang J; Tang L; Li L; Wong KK; Song D; Yang X; Liu J; Li X
    Nat Commun; 2021 Aug; 12(1):4853. PubMed ID: 34381046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
    Hussenet T; du Manoir S
    Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
    Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
    Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.
    White RA; Neiman JM; Reddi A; Han G; Birlea S; Mitra D; Dionne L; Fernandez P; Murao K; Bian L; Keysar SB; Goldstein NB; Song N; Bornstein S; Han Z; Lu X; Wisell J; Li F; Song J; Lu SL; Jimeno A; Roop DR; Wang XJ
    J Clin Invest; 2013 Oct; 123(10):4390-404. PubMed ID: 23999427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mesenchymal-like subpopulation in non-neuroendocrine SCLC contributes to metastasis.
    Jin Y; Xiao T; Feng Y; Yang J; Guo C; Hu L; Ji H
    J Genet Genomics; 2021 Jul; 48(7):571-581. PubMed ID: 34373217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
    Dong Z; Guo W; Guo Y; Kuang G; Yang Z
    Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PTEN in basal cell derived lung carcinogenesis.
    Malkoski SP; Cleaver TG; Thompson JJ; Sutton WP; Haeger SM; Rodriguez KJ; Lu SL; Merrick D; Wang XJ
    Mol Carcinog; 2014 Oct; 53(10):841-6. PubMed ID: 23625632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis.
    Li X; Ke Y; Hernandez AL; Yu J; Bian L; Hall SC; Nolan K; Wang JH; Young CD; Wang XJ
    Cancer Lett; 2023 Aug; 570():216330. PubMed ID: 37524225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
    Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
    Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.
    Zhang J; Han C; Ungerleider N; Chen W; Song K; Wang Y; Kwon H; Ma W; Wu T
    Hepatology; 2019 Apr; 69(4):1549-1563. PubMed ID: 30014520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.